30/06/2019 30/06/2020 30/06/2021 30/06/2022 1 ACV (USD) $1,850,000 $4,000,000 $9,800,000 $18,200,000 2 Revenue (AUD) $443,504 24% $1,228,165 31% $3,983,603 41% $9,656,870 3 Cash Receipts $851,860 46% $1,843,086 46% $4,069,794 42% $7,853,399 4 Receivables $535,560 29% $602,990 15% $1,051,698 11% $3,490,000
Open to everyones feedback but going by the past few years the relationship to ACV that I have been able to find is that ACV for the previous year tends to be pretty close to the total revenue for the following year. It was quite close in 2021 and 2022 - if we get anywhere near the same for 2023 I will be very happy!
- Forums
- ASX - By Stock
- ACV & Revenue / cash received mismatch
30/06/201930/06/202030/06/202130/06/2022ACV (USD) $ 1,850,000 $...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 3DP (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.4¢ |
Change
0.011(17.5%) |
Mkt cap ! $59.57M |
Open | High | Low | Value | Volume |
6.9¢ | 8.1¢ | 6.5¢ | $787.7K | 10.79M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 7.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.4¢ | 181246 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 0.073 |
4 | 127892 | 0.070 |
3 | 322478 | 0.069 |
3 | 281800 | 0.068 |
2 | 115000 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.074 | 181246 | 2 |
0.075 | 58907 | 2 |
0.077 | 25000 | 1 |
0.078 | 25001 | 1 |
0.079 | 160746 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
3DP (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online